Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy - Concepedia

Concepedia

Publication | Closed Access

Phase III double-blind comparison of intravenous ondansetron and metoclopramide as antiemetic therapy for patients receiving multiple-day cisplatin-based chemotherapy

63

Citations

10

References

1992

Year

George W. Sledge, Lawrence H. Einhorn, Catherine Nag, Karen House

Abstract

Ondansetron is superior to metoclopramide as antiemetic therapy for multiple-day cisplatin-based chemotherapy.

References

	Year	Citations

Page 1